摘要
在2020年的全球肿瘤流行病统计数据(GLOBOCAN)报告中,女性乳腺癌已经超过肺癌,成为最常见的诊断癌症。研究表明,乳腺癌新辅助化疗(Neoadjuvant chemotherapy, NAC)可有效增加外科手术乳腺的保存率,提高病变的控制率和综合生存率,而对于评价乳腺癌新辅助化疗疗效,影像学在其中起了重要作用。本文主要阐述不同影像技术对于乳腺癌新辅助化疗后疗效评价的现状及进展作一综述。
In the 2020 Global Cancer Epidemic Statistics (GLOBOCAN) report, female breast cancer has ex-ceeded lung cancer and become the most common diagnostic cancer. Studies have shown that neo-adjuvant chemotherapy (NAC) for breast cancer can effectively increase the survival rate of surgical breast, improve the control rate of lesions and the overall survival rate, and imaging plays an im-portant role in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer. This article reviews the current status and progress of different imaging techniques in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer.
出处
《临床医学进展》
2022年第7期6013-6018,共6页
Advances in Clinical Medicine
